PPBTNasdaq

PURPLE BIOTECH LTD.

Healthcare·Healthcare·Rehovot, Israel

PURPLE BIOTECH LTD. (PPBT): 1 pipeline candidate · ~5 mo cash runway. Updated within the last hour.

2.3/10

BioSniper Score

2-factor signal · derived from public data

Cash Runway1.3

4.8 months

Financial HealthN/A

N/A

Pipeline MaturityN/A

N/A

Pipeline Breadth3.3

1 candidate

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for PURPLE BIOTECH LTD.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$1.7M

Cash

$8.7M

Quarterly Burn

$5.7M

Runway

4.8 mo

Revenue

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Nov 2026
Today~7 mo out
Catalyst within runway

Pipeline (1 candidate)

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

13

Total value held

$305K

HolderSharesValue
susquehanna international group, llp53,403$216K
smartharvest portfolios, llc18,127$73K
bnp paribas financial markets1,957$8K
rhumbline advisers710$3K
simplex trading, llc597$2K
morgan stanley578$2K
gamma investing llc108$436
group one trading llc20$81
advisory services network, llc9$36
northwestern mutual wealth management co8$32

Showing top 10 of 13 institutional holders of PURPLE BIOTECH LTD.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

·CEO: Mr. Gil Efron CPA, M.A.

Frequently asked questions

How many drug candidates are in PURPLE BIOTECH LTD.'s pipeline?

PURPLE BIOTECH LTD. (PPBT) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.

What is PURPLE BIOTECH LTD.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, PURPLE BIOTECH LTD. has approximately 4.8 months of cash runway.

What is PURPLE BIOTECH LTD.'s market capitalization?

PURPLE BIOTECH LTD.'s market capitalization is approximately $1.7M.

Who is the CEO of PURPLE BIOTECH LTD.?

Mr. Gil Efron CPA, M.A. is the chief executive officer of PURPLE BIOTECH LTD. (PPBT).

Get the full picture on PURPLE BIOTECH LTD.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.